phenytoin has been researched along with Chronic Kidney Disease-Mineral and Bone Disorder in 1 studies
Chronic Kidney Disease-Mineral and Bone Disorder: Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three children with azotaemic renal osteodystrophy were treated with 1,25-dihydroxycholecalciferol (1,25(OH)2D3)." | 1.26 | 1,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy. ( Dellagrammatikas, H; Ellis, HA; Norman, AW; Pierides, AM; Scott, JE, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pierides, AM | 1 |
| Ellis, HA | 1 |
| Dellagrammatikas, H | 1 |
| Scott, JE | 1 |
| Norman, AW | 1 |
1 other study available for phenytoin and Chronic Kidney Disease-Mineral and Bone Disorder
| Article | Year |
|---|---|
1,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy.
Topics: Adolescent; Bone and Bones; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Dihy | 1977 |